Cargando…
Molecular assays for the detection of microRNAs in prostate cancer
BACKGROUND: MicroRNAs (miRNAs) are small non-coding RNAs (about 21 to 24 nucleotides in length) that effectively reduce the translation of their target mRNAs. Several studies have shown miRNAs to be differentially expressed in prostate cancer, many of which are found in fragile regions of chromosome...
Autores principales: | Siva, Amara C, Nelson, Luke J, Fleischer, Chad L, Majlessi, Mehrdad, Becker, Michael M, Vessella, Robert L, Reynolds, Mark A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656451/ https://www.ncbi.nlm.nih.gov/pubmed/19267923 http://dx.doi.org/10.1186/1476-4598-8-17 |
Ejemplares similares
-
MicroRNAs in prostate cancer
por: Kim, Won Tae, et al.
Publicado: (2012) -
microRNAs and prostate cancer
por: Shi, Xu-Bao, et al.
Publicado: (2008) -
Circulating MicroRNAs as Biomarkers of Prostate Cancer: The State of Play
por: Sapre, Nikhil, et al.
Publicado: (2013) -
Diet, MicroRNAs and Prostate Cancer
por: Saini, Sharanjot, et al.
Publicado: (2010) -
Interbase-FRET binding assay for pre-microRNAs
por: Bood, Mattias, et al.
Publicado: (2021)